Attached files
file | filename |
---|---|
EX-10.29 - CIPHERLOC Corp | ex10-29.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of the earliest event reported): September 26, 2018
Cipherloc Corporation
(Exact name of registrant as specified in its charter)
(formerly National Scientific Corporation)
Texas | 000-28745 | 86-0837077 | ||
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
825 Main Street
Suite 100
Buda, Texas 78610
(Address of principal executive offices) (Zip Code)
702-818-9011
Registrant’s telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Section 5 - Corporate Governance and Management
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
On September 24, 2018 the Board of Directors appointed Dr. Milton Mattox as Chief Operating Officer of the Company. Commencing October 1, 2018, Dr. Mattox shall oversee the development of the Company’s Business and operate the Company on a day to day basis reporting directly to the President/CEO.
Dr. Milton Mattox is an experienced, senior technology executive with an extensive background in software engineering, application development, IT infrastructure and offshore Research and Development (R&D) team management. This includes a proven track record of transforming and accelerating technology development and delivery in alignment with the goals of the business worldwide. His professional experience includes an executive vice president position at Lucent Technologies with executive level experience at Intuit, Mitel, SHPS, Narus India, Cigna, and CGI.
Dr. Mattox holds a Doctorate in Organization and Leadership, University of San Francisco an M.B.A from City University of Seattle, a Bachelor of Science, Electronic Engineering Technology, DeVry University and a Global Leadership Certification Program, Thunderbird School of Global Management
There are no transactions involving the newly appointed Chief Operating Officer that are reportable under Item 404(a) of Regulation S-K for the purposes of this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits
Exhibit 10.29 Employment Agreement Milton Mattox.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Registrant | Cipherloc Corporation | |
Date: September 26, 2018 | By: | /s/ Michael De La Garza |
Michael De La Garza | ||
Chief Executive Officer (Principal Executive Officer) and Director |